Your browser doesn't support javascript.
loading
MCH Regulates SIRT1/FoxO1 and Reduces POMC Neuronal Activity to Induce Hyperphagia, Adiposity, and Glucose Intolerance.
Al-Massadi, Omar; Quiñones, Mar; Clasadonte, Jerome; Hernandez-Bautista, René; Romero-Picó, Amparo; Folgueira, Cintia; Morgan, Donald A; Kalló, Imre; Heras, Violeta; Senra, Ana; Funderburk, Samuel C; Krashes, Michael J; Souto, Yara; Fidalgo, Miguel; Luquet, Serge; Chee, Melissa J; Imbernon, Monica; Beiroa, Daniel; García-Caballero, Lucía; Gallego, Rosalia; Lam, Brian Y H; Yeo, Giles; Lopez, Miguel; Liposits, Zsolt; Rahmouni, Kamal; Prevot, Vincent; Dieguez, Carlos; Nogueiras, Ruben.
Afiliação
  • Al-Massadi O; Department of Physiology, CIMUS, Universidad de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Quiñones M; CIBER Fisiopatología de la Obesidad y Nutrición, Santiago de Compostela, Spain.
  • Clasadonte J; Department of Physiology, CIMUS, Universidad de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Hernandez-Bautista R; CIBER Fisiopatología de la Obesidad y Nutrición, Santiago de Compostela, Spain.
  • Romero-Picó A; Unité de Biologie Fonctionnelle et Adaptative, CNRS UMR 8251, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
  • Folgueira C; INSERM, U1172, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Center, Lille, France.
  • Morgan DA; FHU 1000 Days for Health, School of Medicine, University of Lille, Lille, France.
  • Kalló I; Department of Physiology, CIMUS, Universidad de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Heras V; Department of Physiology, CIMUS, Universidad de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Senra A; CIBER Fisiopatología de la Obesidad y Nutrición, Santiago de Compostela, Spain.
  • Funderburk SC; Department of Physiology, CIMUS, Universidad de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Krashes MJ; CIBER Fisiopatología de la Obesidad y Nutrición, Santiago de Compostela, Spain.
  • Souto Y; Department of Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, and Iowa City VA Health Care System, Iowa City, IA.
  • Fidalgo M; Laboratory of Endocrine Neurobiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary.
  • Luquet S; Department of Physiology, CIMUS, Universidad de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Chee MJ; CIBER Fisiopatología de la Obesidad y Nutrición, Santiago de Compostela, Spain.
  • Imbernon M; Department of Physiology, CIMUS, Universidad de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Beiroa D; Diabetes, Endocrinology, and Obesity Branch, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
  • García-Caballero L; Diabetes, Endocrinology, and Obesity Branch, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
  • Gallego R; Department of Physiology, CIMUS, Universidad de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Lam BYH; Department of Physiology, CIMUS, Universidad de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Yeo G; Unité de Biologie Fonctionnelle et Adaptative, CNRS UMR 8251, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
  • Lopez M; Division of Endocrinology, Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School, Boston, MA.
  • Liposits Z; Department of Physiology, CIMUS, Universidad de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Rahmouni K; CIBER Fisiopatología de la Obesidad y Nutrición, Santiago de Compostela, Spain.
  • Prevot V; INSERM, U1172, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Center, Lille, France.
  • Dieguez C; Department of Physiology, CIMUS, Universidad de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
  • Nogueiras R; CIBER Fisiopatología de la Obesidad y Nutrición, Santiago de Compostela, Spain.
Diabetes ; 68(12): 2210-2222, 2019 12.
Article em En | MEDLINE | ID: mdl-31530579
ABSTRACT
Melanin-concentrating hormone (MCH) is an important regulator of food intake, glucose metabolism, and adiposity. However, the mechanisms mediating these actions remain largely unknown. We used pharmacological and genetic approaches to show that the sirtuin 1 (SIRT1)/FoxO1 signaling pathway in the hypothalamic arcuate nucleus (ARC) mediates MCH-induced feeding, adiposity, and glucose intolerance. MCH reduces proopiomelanocortin (POMC) neuronal activity, and the SIRT1/FoxO1 pathway regulates the inhibitory effect of MCH on POMC expression. Remarkably, the metabolic actions of MCH are compromised in mice lacking SIRT1 specifically in POMC neurons. Of note, the actions of MCH are independent of agouti-related peptide (AgRP) neurons because inhibition of γ-aminobutyric acid receptor in the ARC did not prevent the orexigenic action of MCH, and the hypophagic effect of MCH silencing was maintained after chemogenetic stimulation of AgRP neurons. Central SIRT1 is required for MCH-induced weight gain through its actions on the sympathetic nervous system. The central MCH knockdown causes hypophagia and weight loss in diet-induced obese wild-type mice; however, these effects were abolished in mice overexpressing SIRT1 fed a high-fat diet. These data reveal the neuronal basis for the effects of MCH on food intake, body weight, and glucose metabolism and highlight the relevance of SIRT1/FoxO1 pathway in obesity.
Assuntos

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Hormônios Hipofisários / Pró-Opiomelanocortina / Hiperfagia / Intolerância à Glucose / Adiposidade / Sirtuína 1 / Proteína Forkhead Box O1 / Hormônios Hipotalâmicos / Melaninas / Neurônios Limite: Animals Idioma: En Revista: Diabetes Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Hormônios Hipofisários / Pró-Opiomelanocortina / Hiperfagia / Intolerância à Glucose / Adiposidade / Sirtuína 1 / Proteína Forkhead Box O1 / Hormônios Hipotalâmicos / Melaninas / Neurônios Limite: Animals Idioma: En Revista: Diabetes Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha